BARD LIMITED, a worldwide market-leader in urological drainage and continence products, has nearly 100 years of experience in researching and developing innovative products to meet the changing needs of healthcare professionals and patients.
BARDEX I.C. Foley catheters have been shown to reduce the incidence of catheterassociated urinary tract infection (CAUTI) by 32%-69% compared with conventional catheters, potentially saving a typical 600 bed hospital £181,600 per year. This range is now available through NHS Logistics and on prescription.
Another recent Bard innovation is the introduction of the EZ-Lok needle-free sample port on the Bard range of urinemeters. The risk of needlestick injury in urine sampling can be eliminated with this unique, easy-to-use locking system which is compatible with Luer lock syringes for a self-sealing, leak-proof fit.
